Study guide

1.7 Healthcare Reimbursement Systems Across Care Settings

PTCB Billing and Reimbursement Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

0.1 PTCB Billing & Reimbursement Exam Facts 0.2 Blueprint Breakdown & Study Strategy

2 Chapter 1: Third-Party Programs & Eligibility

1.1 Commercial Insurance & Managed Care Models 1.2 Medicare Pharmacy Coverage: Parts A, B, C, and D 1.3 Medicaid, Dual Eligibles, & Government Safety-Net Programs 1.4 Military, Veterans, & Worker's Compensation Programs 1.5 Patient Assistance Programs, Copay Cards, & 340B Drug Pricing 1.6 Patient Eligibility Verification & Coordination of Benefits (COB) 1.7 Healthcare Reimbursement Systems Across Care Settings

3 Chapter 2: Pharmacy Claims Processing & Adjudication

2.1 NCPDP Telecommunication Standards & Claim Data Elements 2.2 Pharmacy Pricing Structures & Cost Determinations 2.3 Patient Cost-Sharing Calculations: Copays, Coinsurance, & Deductibles 2.4 Dispense as Written (DAW) Codes & Product Selection Logic 2.5 Real-Time Adjudication Workflow & Claim Lifecycle 2.6 NCPDP Reject Codes & Troubleshooting Strategies 2.7 Drug Utilization Review (DUR) & Submission Clarification Codes 2.8 Compound, Specialty, & Partial Fill Adjudication

4 Chapter 3: Prior Authorization & Appeals

3.1 Formulary Management & Utilization Management Controls 3.2 Prior Authorization Criteria & Clinical Documentation Requirements 3.3 Electronic Prior Authorization (ePA) & Submission Portals 3.4 PA Denials, Peer-to-Peer Reviews, & Formal Appeals

5 Chapter 4: Audits & Compliance

4.1 PBM Audit Types, Triggers, & Procedures 4.2 Prescription Documentation, Signature Capture, & Record Retention 4.3 Fraud, Waste, and Abuse (FWA), False Claims, & Regulatory Compliance

6 Chapter 5: Medical Claims Processing & Adjudication

5.1 Medical vs. Pharmacy Benefit Billing & Clinical Pharmacy Services 5.2 Medical Coding Systems (CPT, HCPCS, ICD-10) & CMS-1500 Billing

1.7 Healthcare Reimbursement Systems Across Care Settings

Key Takeaways Explain This Topic AI

The identical drug can follow entirely different reimbursement systems depending on the site of care: bundled into an MS-DRG or PDPM per-diem during inpatient/SNF stays, billed under the pharmacy benefit at retail, and reimbursed under the medical benefit (buy-and-bill, ASP + 6%) in clinics and hospital outpatient departments.

For custodial nursing home residents, Medicaid pays room and board while the LTC pharmacy bills Medicare Part D for drugs; CMS mandates 14-day-or-less short-cycle dispensing of brand oral solids to LTC residents to reduce waste.

Home infusion drugs are covered under Medicare Part B only when they require durable medical equipment (e.g., an external infusion pump), with professional services paid under the Part B home infusion therapy benefit created by the 21st Century Cures Act.

Home health medications are bundled into the PDGM 30-day episode payment and are not separately billable, while ambulatory clinics use medical-benefit buy-and-bill billing with incident-to pharmacist services.

Last updated: August 2026

1.7 Healthcare Reimbursement Systems Across Care Settings

The PTCB Billing and Reimbursement content outline explicitly tests healthcare reimbursement systems in different settings — because the identical drug can travel through entirely different benefit structures, claim formats, and payment formulas depending on where the patient receives care. A single course of antibiotics, for example, is bundled into an MS-DRG payment during an inpatient admission, adjudicated in real time under the pharmacy benefit when dispensed as oral step-down therapy at a community pharmacy, and reimbursed under the medical benefit when infused at home through durable equipment.

Billing specialists must instantly recognize which reimbursement system governs a given site of care, which claim standard applies (NCPDP D.0 vs. CMS-1500/837P vs. UB-04/837I), and how bundling rules determine whether a drug is separately billable at all.

Care Setting Dominant Payer & Benefit Drug Reimbursement Mechanics

Community / Retail Pharmacy Pharmacy benefit (Medicare Part D, Medicaid, commercial PBMs) Real-time NCPDP D.0 point-of-sale adjudication; tiered copays; Lower of Logic pricing.

Hospital Inpatient Medicare Part A / commercial per-case rates Drugs bundled into MS-DRG per-discharge payment; no separate drug claims.

Hospital Outpatient (HOPD) Medicare Part B (OPPS) / commercial medical benefit Buy-and-bill; HCPCS/CPT on CMS-1500 or UB-04; ASP + 6% for separately payable drugs.

Long-Term Care (SNF / Nursing Home) Part A SNF bundle (post-acute); Part D for custodial residents Part A per-diem (PDPM) bundles drugs; custodial dual-eligibles bill Part D via LTC pharmacy.

Home Infusion Medicare Part B (DME-linked) / commercial medical benefit Pump-associated drugs covered as DME; per-diem professional services benefit; per-diem + drug commercial bundles.

Home Health Medicare Part A/B episode bundle (PDGM) Most drugs bundled into the 30-day episode payment; not separately billable.

Ambulatory Clinics / Physician Offices Medical benefit (Part B / commercial major medical) Buy-and-bill HCPCS J-codes; incident-to pharmacist services billed under supervising physician NPI.

Specialty / Mail-Order Pharmacy Pharmacy benefit (PBM) NCPDP real-time adjudication; limited distribution networks; cold-chain fulfillment.

1. Hospitals: Bundled Inpatient vs. Itemized Outpatient Billing

Inpatient (Part A): Medicare pays acute-care hospitals a single prospectively determined MS-DRG (Medicare Severity Diagnosis-Related Group) case rate per discharge. Every tablet, IV bag, and supply used during the admission is absorbed into that bundle — pharmacies never submit NCPDP or CMS-1500 claims for individual inpatient drugs. Skilled nursing facility stays following a qualifying 3-day inpatient admission are paid under the Patient-Driven Payment Model (PDPM) per-diem, which likewise bundles routine drug costs.

Hospital Outpatient Departments (Part B / OPPS): Hospital outpatient clinics and infusion suites bill Medicare Part B under the Outpatient Prospective Payment System (OPPS) , which packages services into Ambulatory Payment Classifications (APCs) . Separately payable physician-administered drugs reimburse at ASP + 6% under buy-and-bill (Section 5.1), with claims carrying HCPCS J-codes, CPT administration codes, and JW/JZ wastage modifiers (Section 5.2).

2. Long-Term Care Pharmacy Reimbursement

Long-term care reimbursement hinges on whether the resident is in a post-acute Medicare Part A SNF stay or a custodial long-term stay :

Part A SNF Stay (up to 100 days per benefit period): All medications are bundled into the facility's PDPM per-diem; the LTC pharmacy bills the nursing facility under contract rather than a third-party plan.

Custodial Residents: Medicaid typically pays room and board, while prescription drugs for dual-eligible residents are billed by the LTC pharmacy to Medicare Part D through real-time NCPDP claims (Medicaid remains the payer of last resort).

CMS Short-Cycle Dispensing Mandate: To reduce waste from therapy changes, discharges, and dose adjustments, Part D plans must require LTC pharmacies to dispense brand-name oral solid maintenance drugs to LTC residents in 14-day-or-less dispensing cycles (tracked with LTC-specific Submission Clarification Codes) rather than traditional 30-day fills.

3. Home Infusion & Home Health

Home Infusion: For Medicare beneficiaries, IV drugs administered at home are covered under Part B only when the drug requires durable medical equipment — typically an external ambulatory infusion pump (e.g., certain IV antibiotics, inotropes such as dobutamine, or immune globulin). The drug and pump bill to the DME MAC; the 21st Century Cures Act additionally created a Part B professional services benefit that pays accredited home infusion suppliers a per-diem for nursing visits, training, and monitoring. Commercial payers typically reimburse home infusion under the medical benefit as a negotiated per-diem plus drug and supply bundle, requiring ACHC or Joint Commission accreditation.

Home Health: Medicare pays certified home health agencies a bundled 30-day episode payment under the Patient-Driven Groupings Model (PDGM) . Routine medications and supplies used during the episode are bundled and cannot be billed separately; only DME (e.g., walkers, wound-care supplies) is carved out and billed to the DME MACs.

4. Ambulatory Clinics & Community Pharmacy

Ambulatory Clinics / Physician Offices: Operate under the medical benefit with buy-and-bill economics (ASP + 6%), CMS-1500/837P claims, and — increasingly — pharmacist-delivered services (Annual Wellness Visits, Chronic Care Management, MTM) billed under incident-to arrangements with supervising physicians (detailed in Section 5.2).

Community Pharmacy: The dominant pharmacy-benefit channel: real-time NCPDP D.0 adjudication to PBMs, tiered copays, and point-of-sale DUR. Mail-order and specialty pharmacies use the same standard with 90-day supply economics and limited-distribution exclusivity.

Note

Exam Trap: The same product changes coverage pathway purely by site of care. Albuterol solution billed through a home nebulizer is Part B DME; the same patient's handheld inhaler at retail is Part D; the same drug during an inpatient admission is invisible inside the MS-DRG bundle.